Ashford Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ashford Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-142,737	Closed	-$1.53M	–	103
2019 Q1	$1.53M	Sell	142,737 -149,392	-51%	-$1.6M	0.22%	56
2018 Q4	$2.56M	Sell	292,129 -245,515	-46%	-$3.13M	0.42%	44
2018 Q3	$9.03M	Buy	537,644 +111,942	+26%	+$2.42M	1.09%	33
2018 Q2	$8.92M	Sell	425,702 -103,013	-19%	-$1.91M	1.18%	30
2018 Q1	$8.51M	Buy	528,715 +166,100	+46%	+$3.29M	1.28%	28
2017 Q4	$6.87M	Buy	+362,615	New	+$6.57M	1.07%	31
2015 Q4	–	Sell	-1,224,692	Closed	-$7.32M	–	119
2015 Q3	$7.32M	Sell	1,224,692 -25,127	-2%	-$174K	1.72%	19
2015 Q2	$8.55M	Sell	1,249,819 -11,343	-0.9%	-$72K	1.89%	21
2015 Q1	$7.66M	Buy	1,261,162 +103,092	+9%	+$686K	1.56%	23
2014 Q4	$8.03M	Buy	1,158,070 +163,950	+16%	+$1.21M	1.6%	20
2014 Q3	$8.09M	Buy	994,120 +223,600	+29%	+$1.75M	1.74%	16
2014 Q2	$6.26M	Buy	770,520 +223,116	+41%	+$1.69M	1.26%	28
2014 Q1	$4.29M	Buy	+547,404	New	+$4.63M	0.83%	50

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ashford Capital Management's SPPI Position: Q2 2019 in Review

Ashford Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 142,737 shares — an estimated $1.53M sold.

Ashford Capital Management first reported a position in SPPI in Q1 2014 and held it in 13 quarters. The position peaked at $9.03M in Q3 2018. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

Ashford Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
Ashford Capital Management sold 142,737 Spectrum Pharmaceuticals Inc shares in Q2 2019, an estimated $1.53M.
Ashford Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2014 and held it in 13 quarters.
Ashford Capital Management's Spectrum Pharmaceuticals Inc position peaked at $9.03M in Q3 2018.
165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on Ashford Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.